Xenotransplantation: regulatory challenges

Area of Science:

• Biomedical Science
• Public Health Policy
• Regulatory Affairs

Background:

• Xenotransplantation, the transplantation of non-human organs into humans, presents unique scientific and ethical challenges.
• The late 1990s saw increased interest and development in xenotransplantation research.
• A need for clear governmental oversight and guidance was recognized.

Purpose of the Study:

• To document the US government's regulatory and policy actions concerning xenotransplantation during 1999-2000.
• To identify key issues discussed in public forums regarding xenotransplantation.
• To provide a historical overview of early US governmental engagement with xenotransplantation.

Main Methods:

• Review of published policy and guidance documents from US government agencies.
• Analysis of records from public meetings of advisory committees.
• Identification of the issuing bodies and dates of relevant documents.

Main Results:

• The Public Health Service published one policy/guidance document.
• The Food and Drug Administration (FDA) published two policy/guidance documents.
• The FDA's xenotransplantation subcommittee held two public meetings to discuss specific issues.

Conclusions:

• The US government actively engaged in developing policy and guidance for xenotransplantation during 1999-2000.
• Public discourse and regulatory development were concurrent in the early stages of US xenotransplantation policy.
• These actions laid groundwork for future regulatory frameworks governing human xenotransplantation efforts.